The words approved in red and spelled out in capitals.T

Glenmark obtains FDA OK for generic Cardizem

Cardizem had a market value of approximately $56.7 million for the 12 months ended January 2021, according to IQVIA.
Levy

The Food and Drug Administration has given Glenmark the green light for diltiazem hydrochloride ER capsules, in dosage strengths of 60 mg, 90 mg, and 120 mg.

The product is the generic of Biovail Laboratories’ Cardizem. It is used to treat high blood pressure (hypertension) and prevent chest pain (angina).

Glenmark has been granted a competitive generic therapy designation for its generic and is eligible for 180 days of CGT exclusivity upon commercial marketing.

Cardizem had a market value of approximately $56.7 million for the 12 months endedJanuary 2021, according to IQVIA.

X
This ad will auto-close in 10 seconds